Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

NCT07321652

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Jupiter Medical Center Jupiter, Florida, United States
  • Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
  • Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho, United States
View all 152 locations
View Trial Details
Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

NCT07215910

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 3, Glioma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 82 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

NCT05131022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 62 locations
View Trial Details
Recruiting

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT03802695

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations
  • City of Hope Duarte, California, United States
  • UC Davis Sacramento, California, United States
  • Stanford Health Care Stanford, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

STimulation to Activate RespIration

NCT06832306

Conditions
AHRF, ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, +10 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Louisiana State University Health Sciences Shreveport, Louisiana, United States
  • Wake Forest University School of Medicine Winston-Salem, North Carolina, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions